Hearing and colleagues showed that while IFNs fail to inhibit HAdV replication in cancer cell lines, replication in “normal” human cells could be inhibited by IFN-α and IFN-γ via repression of transcription of the E1A immediate early gene product. This evidence concerns the gene IFNG and cancer.